Susan M. Galli
Susan was a partner in the life sciences and intellectual property transactions practice groups until her retirement in 2018. She focused her practice on advising pharmaceutical, biotech, medical device and other technology companies on licensing, collaboration and research agreements, joint ventures, asset acquisitions and divestitures, and other major transactions. Susan also advised research institutions on developing vehicles for translational research and on structuring transactions with industry, the government and other institutions.
- Speaker, “Current Issues in Technology Transfer,” Ropes & Gray Roundtable (November 2, 2018)
- Speaker, “New Funding Frontiers: Innovative Funding Models in Translational Research,” Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (October, 1, 2018)